HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chiharu Kishimoto Selected Research

Myocarditis (Carditis)

3/2015N-Acetylcysteine Ameliorates Experimental Autoimmune Myocarditis in Rats via Nitric Oxide.
1/2015Nucleotide differences of coxsackievirus B3 and chronic myocarditis.
5/2014Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance.
9/2013Erythromycin treatment suppresses myocardial injury in autoimmune myocarditis in rats via suppression of superoxide production.
7/2013Immunoglobulin treatment ameliorates myocardial injury in experimental autoimmune myocarditis associated with suppression of reactive oxygen species.
9/2010Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, improves experimental autoimmune myocarditis in rats via nitric oxide.
11/2008Naloxone, an opiate receptor antagonist, ameliorates acute experimental autoimmune myocarditis by reducing cytotoxic activities.
10/2008L-arginine ameliorates experimental autoimmune myocarditis by maintaining extracellular matrix and reducing cytotoxic activity of lymphocytes.
5/2006Relevance of inflammatory cell infiltrates for complete atrioventricular block in experimental murine myocarditis.
12/2005MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chiharu Kishimoto Research Topics

Disease

38Myocarditis (Carditis)
03/2015 - 07/2002
16Atherosclerosis
09/2012 - 03/2003
7Heart Failure
07/2013 - 07/2002
5Body Weight (Weight, Body)
12/2005 - 09/2003
4Cardiomyopathies (Cardiomyopathy)
05/2014 - 06/2003
4Pericardial Effusion
09/2005 - 09/2003
4Heart Diseases (Heart Disease)
09/2004 - 08/2002
4Inflammation (Inflammations)
06/2003 - 08/2002
3Atherosclerotic Plaque (Atheroma)
09/2011 - 06/2006
2Acute Coronary Syndrome
10/2007 - 08/2002
2Coronary Artery Disease (Coronary Atherosclerosis)
10/2007 - 04/2003
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
10/2003 - 08/2002
1Disease Progression
05/2014
1Hypokalemia
01/2014
1Uremia
10/2011
1Cerebral Infarction
04/2011
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
04/2011
1Cardiovascular Diseases (Cardiovascular Disease)
12/2010
1Hypotension (Low Blood Pressure)
11/2008
1Neoplasms (Cancer)
11/2008
1Chest Pain (Chest Pains)
10/2007
1Myocardial Infarction
11/2006
1Atrial Fibrillation
11/2006
1Hypersensitivity (Allergy)
09/2005
1Atrioventricular Block
07/2005
1Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
01/2004
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
06/2003
1Coronary Vasospasm (Coronary Artery Vasospasm)
04/2003
1Muscle Spasticity (Spastic)
04/2003

Drug/Important Bio-Agent (IBA)

14ApolipoproteinsIBA
09/2012 - 03/2003
11Immunoglobulins (Immunoglobulin)IBA
05/2014 - 10/2002
11CytokinesIBA
05/2014 - 06/2003
11ThioredoxinsIBA
09/2004 - 08/2002
8AntioxidantsIBA
03/2015 - 08/2002
8Apolipoproteins E (ApoE)IBA
09/2012 - 01/2006
7Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2015 - 07/2002
7CholesterolIBA
09/2012 - 08/2003
7Proteins (Proteins, Gene)FDA Link
06/2004 - 08/2002
5NG-Nitroarginine Methyl Ester (L-NAME)IBA
03/2015 - 07/2002
5LigandsIBA
06/2012 - 09/2003
5PPAR gammaIBA
10/2007 - 09/2003
5Fc Receptors (Fc Receptor)IBA
06/2006 - 09/2002
5Cardiac MyosinsIBA
09/2005 - 01/2003
4Nitric Oxide Synthase (NO Synthase)IBA
10/2008 - 07/2002
3Acetylcysteine (Siran)FDA LinkGeneric
03/2015 - 06/2004
3Myosins (Myosin)IBA
09/2013 - 09/2004
3Superoxides (Superoxide)IBA
09/2013 - 07/2009
3Carvedilol (Coreg)FDA LinkGeneric
09/2012 - 01/2004
3Arginine (L-Arginine)FDA Link
10/2008 - 07/2002
3Free Radical ScavengersIBA
09/2006 - 01/2004
3EdaravoneIBA
09/2006 - 01/2004
3Neutralizing AntibodiesIBA
06/2005 - 09/2002
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
06/2003 - 08/2002
3temocapril hydrochloride (temocapril)IBA
06/2003 - 08/2002
2Intravenous Immunoglobulins (IVIG)FDA Link
05/2014 - 10/2003
2Pharmaceutical PreparationsIBA
09/2013 - 09/2002
2olmesartanIBA
09/2005 - 04/2004
2Propranolol (Inderal)FDA LinkGeneric
04/2004 - 01/2004
2Metoprolol (Toprol-XL)FDA LinkGeneric
04/2004 - 01/2004
2Free RadicalsIBA
01/2004 - 09/2002
2AntigensIBA
11/2003 - 01/2003
2ImmunosorbentsIBA
04/2003 - 08/2002
2EnzymesIBA
04/2003 - 08/2002
1NucleotidesIBA
01/2015
1ElectrolytesIBA
01/2014
1Erythromycin (Erycette)FDA LinkGeneric
09/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2013
1C-Reactive ProteinIBA
06/2012
1Antigen-Antibody Complex (Immune Complex)IBA
06/2012
1Pioglitazone (Actos)FDA Link
10/2011
1Biomarkers (Surrogate Marker)IBA
04/2011
1MicroRNAs (MicroRNA)IBA
04/2011
1CholatesIBA
12/2010
1(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
12/2010
1CannabinoidsIBA
12/2010
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2010
1Opioid Receptors (Opioid Receptor)IBA
11/2008
1Naloxone (Narcan)FDA LinkGeneric
11/2008
1beta-Endorphin (Endorphin, beta)IBA
11/2008
1Matrix Metalloproteinases (MMPs)IBA
10/2007
1Transcription Factors (Transcription Factor)IBA
10/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2007
1Dipyridamole (Persantine)FDA LinkGeneric
11/2006
1Hydroxyl RadicalIBA
12/2005
1Concanavalin AIBA
12/2004
1ChemokinesIBA
09/2004
1Angiotensin Receptors (Angiotensin II Receptor)IBA
04/2004
1Messenger RNA (mRNA)IBA
01/2004
1coenzyme Q10 (CoQ10)IBA
11/2003
1Immunosuppressive Agents (Immunosuppressants)IBA
10/2003
1Antiviral Agents (Antivirals)IBA
10/2003
1Coloring Agents (Dyes)IBA
06/2003
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
06/2003
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2003
1benidipineIBA
06/2003
11,4-dihydropyridine (dihydropyridine)IBA
06/2003
1Vitamin EFDA LinkGeneric
04/2003

Therapy/Procedure

6Therapeutics
05/2014 - 04/2002
1Exercise Therapy (Therapy, Exercise)
01/2006
1Intra-Aortic Balloon Pumping
10/2002